There is a consensus that overt diabetes mellitus (DM), whether or not accompanied by symptoms or signs of metabolic decompensation, is associated with a significant risk of adverse pregnancy outcome. On the other hand, the risk of adverse outcome associated with degrees of glucose intolerance less severe than overt DM is controversial. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study is a basic epidemiologic investigation aiming to clarify unanswered questions on the association of various levels of glucose intolerance during the third trimester of pregnancy and risk of adverse outcomes. Its General Aim -- by means of an international cooperative study involving 16 centers and approximately 25,000 pregnant women -- is to achieve a major advance in knowledge on levels of glucose during pregnancy that place the mother, fetus, and neonate at increased risk. The primary hypothesis is that hyperglycemia during pregnancy, less severe than overt DM, is associated with increased risk of adverse maternal, fetal, and neonatal outcome that is independently related to the degree of metabolic disturbance.
Specific Aims of HAPO are: 1. to examine glucose tolerance in a large, heterogeneous, multinational, multicultural, ethnically diverse cohort of women in the third trimester of gestation with medical caregivers """"""""blinded"""""""" to status of glucose tolerance (except in those instances where fasting and/or two hour OGTT plasma glucose concentration exceeds a predefined cutoff value); and 2. to derive internationally acceptable criteria for the diagnosis and classification of gestational diabetes mellitus (GDM) based on the specific relationships between maternal glycemia and the risk of specific adverse outcomes that are established through this study. The study is to be accomplished with high quality standardized data collection on the women during the third trimester of gestation (including the OGTT) and at time of delivery for assessment of adverse outcomes, including operative delivery (caesarean section), increased fetal size (macrosomia/obesity), neonatal morbidity (hypoglycemia), and fetal hyperinsulinism. HAPO is to include a Clinical Coordinating Center and Data Coordinating Center, both located at the Northwestern University Medical School in Chicago, as well as a Central Laboratory located in Belfast, United Kingdom. This application requests support for the Data Coordinating Center for HAPO. Cost effectiveness for HAPO is enhanced through cost sharing by colleagues in non-U.S. centers.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD034242-05
Application #
6636925
Study Section
Special Emphasis Panel (ZHD1-DRG-H (BM))
Project Start
1999-05-04
Project End
2004-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
5
Fiscal Year
2003
Total Cost
$259,035
Indirect Cost
Name
Northwestern University at Chicago
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Thaware, Parag K; McKenna, Sonia; Patterson, Christopher C et al. (2018) Maternal Lipids at 28 Weeks' Gestation and Offspring Adiposity at Age 5 to 7 Years. J Clin Endocrinol Metab 103:3767-3772
Casey, Claire; McGinty, Ann; Holmes, Valerie A et al. (2018) Maternal vitamin D and neonatal anthropometrics and markers of neonatal glycaemia: Belfast Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Br J Nutr 120:74-80
Casey, C; McGinty, A; Holmes, V A et al. (2018) Maternal vitamin D and markers of glycaemia during pregnancy in the Belfast centre of the Hyperglycaemia and Adverse Pregnancy Outcome study. Diabet Med 35:972-979
Powe, Camille E; Nodzenski, Michael; Talbot, Octavious et al. (2018) Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus. Diabetes 67:2703-2709
Hivert, Marie-France; Scholtens, Denise M; Allard, Catherine et al. (2017) Genetic determinants of adiponectin regulation revealed by pregnancy. Obesity (Silver Spring) 25:935-944
Sandler, Victoria; Reisetter, Anna C; Bain, James R et al. (2017) Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes. Diabetologia 60:518-530
Jacob, Saya; Nodzenski, Michael; Reisetter, Anna C et al. (2017) Targeted Metabolomics Demonstrates Distinct and Overlapping Maternal Metabolites Associated With BMI, Glucose, and Insulin Sensitivity During Pregnancy Across Four Ancestry Groups. Diabetes Care 40:911-919
Petry, C J; Mooslehner, K; Prentice, P et al. (2017) Associations between a fetal imprinted gene allele score and late pregnancy maternal glucose concentrations. Diabetes Metab 43:323-331
Reisetter, Anna C; Muehlbauer, Michael J; Bain, James R et al. (2017) Mixture model normalization for non-targeted gas chromatography/mass spectrometry metabolomics data. BMC Bioinformatics 18:84
Lowe Jr, William L; Bain, James R; Nodzenski, Michael et al. (2017) Maternal BMI and Glycemia Impact the Fetal Metabolome. Diabetes Care 40:902-910

Showing the most recent 10 out of 48 publications